No Picture
News

Precision IBD Announces Next Phase Of Growth: Appoints Mark C. McKenna As President And Chief Executive Officer, Completes Name Change To Prometheus Biosciences, Inc.

Company Plans to Complete Series C Financing in Fourth Quarter of 2019, Followed by Initial Public Offering for 2020

SAN DIEGO, Sept. 5, 2019 /PRNewswire/ — Precision IBD, Inc., a biopharmaceutical company focused on the discovery and development of… […]

No Picture
News

Confirm BioSciences Announces Appointments of Albert Berger as New Chief Executive Officer and Nikhil Nayak as Chief Operating Officer

Former CEO and Founder Zeynep Ilgaz Appointed as Chairwoman of the Board of Directors and Chief Advisor

SAN DIEGO, Aug. 26, 2019 /PRNewswire/ — Confirm BioSciences, a leading developer of high-quality diagnostic testing and health and wellness solut… […]

No Picture
News

Avidity Biosciences Adds Drug Development Veterans Edward Kaye and Noreen Henig to Board of Directors

LA JOLLA, Calif., Aug. 22, 2019 /PRNewswire/ — Avidity Biosciences, a biotechnology company pioneering Antibody-Oligonucleotide Conjugates (AOCs™) focused in rare muscle disorders and other serious diseases, today announced the appointment of Nore… […]

No Picture
News

Erasca Announces Key Leadership Team Appointments and Recruits World-Class Research and Development Advisory Board

Gary Yeung promoted to role of chief operating and financial officerDavid Chacko, M.D., appointed chief business officerLes Brail, Ph.D., joins company as vice president of clinical development and Karen Gilmore appointed vice president of finance

SA… […]